Cargando…
Glutamine antagonism attenuates physical and cognitive deficits in a model of MS
OBJECTIVE: To measure the impact of JHU-083, a novel prodrug of the glutamine antagonist 6-diazo-5-oxo-l-norleucine, on immune cell proliferation and activation, along with physical and cognitive impairments associated with the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. METHO...
Autores principales: | Hollinger, Kristen R., Smith, Matthew D., Kirby, Leslie A., Prchalova, Eva, Alt, Jesse, Rais, Rana, Calabresi, Peter A., Slusher, Barbara S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745721/ https://www.ncbi.nlm.nih.gov/pubmed/31467038 http://dx.doi.org/10.1212/NXI.0000000000000609 |
Ejemplares similares
-
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
por: Bell, Benjamin J., et al.
Publicado: (2022) -
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023) -
FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE
por: Pham, Khoa, et al.
Publicado: (2021) -
OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage
por: Pham, Khoa, et al.
Publicado: (2021) -
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
por: Hanaford, Allison R., et al.
Publicado: (2019)